尊龙凯时·(中国)人生就是搏!

2023.05.15

FDA approves SinoT’s ANDA application for Mesalamine, delayed-release tablets

    Mesalamine, delayed-release tablets is an aminosalicylate indicated for the:1) induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. 2) treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.

美沙拉秦肠溶片.png

    SinoT is a specialty pharma with focus on the research & development, commercialization and sale of complex generics and 505(b2) products. We dedicated to developing high quality medicines that meet with international standards. We’ll do more than our best to benefit the patients in the future.


Shanghai Head Office

99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

Manufacturing Site in Jiangsu

No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

Links
Vastpro
D-innovation
qrcode.jpg

Focus on us

Copyright © 2014-2022 qhess.com.cn ICP:13048014-1   Powered by Yongsy

Privacy Legal

友情链接: